Fluzone® High-Dose Quadrivalent (influenza vaccine) – New formulation approval
November 4, 2019 - Sanofi announced the FDA approval of Fluzone High-Dose Quadrivalent (influenza vaccine), for active immunization for the prevention of influenza caused by influenza A subtype viruses and type B viruses contained in the vaccine. Fluzone High-Dose Quadrivalent is indicated for use in persons 65 years of age and older.
Top